All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
IHE total return snapshot: IHE returned +38.41% over the past year and +20.21% YTD, with dividends reinvested. Since May 5, 2006, IHE is up +715.34% in nominal total return, or +10.81%/yr, and is currently −6.31% below its total-return high on Aug. 19, 2026.
Data ending Fri Oct. 16, 2026
| Fri 2006-05-05💬 to Fri 2026-10-16 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| IHE × |
+715.34%
+10.81%/yr |
+10.56%/yr
R2=0.909 |
||||
| iShares U.S. Pharmaceuticals ETF Exchange-Traded Fund | ||||||
| Fri 2006-05-05💬 to Fri 2026-10-16 |
Start
Value |
End
Value |
|---|---|---|
| IHE × |
$10,000.00
2006-05-05 |
$81,533.53
2026-10-16 |
| YTD | YoY | |
|---|---|---|
| IHE × | +20.21% | +38.41% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| IHE × |
−6.31%
on 2026-10-16 from 2026-08-19 peak |
−38.20%
on 2009-03-05 from 2007-05-22 peak |
| Period ending Fri 2026-10-16 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| IHE × | +38.41% |
+45.34% +20.56%/yr |
+74.79% +20.46%/yr |
+78.81% +12.33%/yr |
+147.34% +9.48%/yr |
| Year | IHE |
|---|---|
| 2026 (YTD) | +20.21% |
| 2025 | +31.69% |
| 2024 | +8.13% |
| 2023 | +1.06% |
| 2022 | −4.87% |
| 2021 | +13.07% |
| 2020 | +13.66% |
| 2019 | +15.47% |
| 2018 | −7.76% |
| 2017 | +10.64% |
| 2016 | −11.75% |
| 2015 | +8.81% |
| 2014 | +29.90% |
| 2013 | +40.59% |
| 2012 | +13.38% |
| 2011 | +20.94% |
| 2010 | +12.71% |
| 2009 | +30.11% |
| 2008 | −14.92% |
| 2007 | +2.37% |
| 2006 | +6.50% |
